Apalutamide – November 2020

• Brand names:
  • Erlyand®
• Pharmaceutical Company:
  • Janssen-Cilag Pty Ltd
• Condition/Indication: Prostate cancer
• Meeting Date: November 2020
• Public Summary Document (PSD) November 2020 PBAC Meeting - (PDF 1911KB)
• Public Summary Document (PSD) November 2020 PBAC Meeting - (Word 1631)

Related Public Summary Documents

• Apalutamide – July 2019

• Apalutamide – November 2021